J&J's Marketing Of Risperdal For Children Slammed In Trial
Law360, Philadelphia (October 15, 2015, 6:32 PM EDT) -- Trial in a third case over abnormal breast growth allegedly caused by a Johnson & Johnson unit’s antipsychotic drug got underway on Thursday as a Philadelphia jury heard arguments that the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
